Streetbeat News

Products Services

AAPL

SSNLF

Samsung is facing a shift in consumer preference in its home market, South Korea, as young millennials and Gen-Z are increasingly buying Apple's iPhones over Samsung's Galaxy smartphones. According to a Gallup Korea survey, 65% of young users are buying iPhones while only 32% are choosing Samsung Galaxy smartphones. This is a 13% increase in iPhone's share amongst young users aged 18-29 years compared to 2022. However, Samsung's upcoming foldable phones could potentially attract these users back.

Portfolio Pulse from Rounak Jain

July 24, 2023 | 10:30 am

KOD

Kodiak Sciences has released topline results from three phase 3 studies of tarcocimab tedromer for neovascular age-related macular degeneration & diabetic macular edema. The DAYLIGHT study met its primary endpoint, but the GLEAM & GLIMMER studies did not. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 10:23 am

GILD

Gilead Sciences has decided to discontinue its Phase 3 ENHANCE study in higher-risk myelodysplastic syndromes due to futility based on a planned analysis. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 10:21 am

SPOT

Spotify has announced a new pricing structure for its premium services. The new prices are $10.99 per month for Premium Single, $14.99 for Premium Duo, and $16.99 for Premium Family. The Premium Student remains at $5.99 per month.

Portfolio Pulse from Charles Gross

July 24, 2023 | 10:16 am

BLTE

Belite Bio has completed enrollment in its global Phase 3 DRAGON trial for patients with Stargardt Disease. The trial is pivotal for the company's drug, Tinlarebant.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 10:07 am

KOD

Kodiak Sciences has released topline results from three Phase 3 studies of Tarcocimab Tedromer for Neovascular Age-related Macular Degeneration & Diabetic Macular Edema. The DAYLIGHT study met its primary endpoint, but the GLEAM & GLIMMER studies did not. Consequently, Kodiak has decided to discontinue further development of Tarcocimab.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 10:04 am

SSNLF

STLA

Stellantis NV (NYSE:STLA) and Samsung SDI have signed a memorandum of understanding to build a second battery manufacturing facility in the U.S. The companies aim to start production in 2027 with an initial annual production capacity of 34 GWh. The new facility is part of the StarPlus Energy joint venture created in May 2022, which had a planned investment of over $2.5 billion.

Portfolio Pulse from Lekha Gupta

July 24, 2023 | 9:55 am

FXI

China's Politburo plans to actively expand domestic demand, including boosting consumption of auto, electronics, and household products, and promoting tourism consumption.

Portfolio Pulse from Charles Gross

July 24, 2023 | 9:25 am

NVDA

NVIDIA's GeForce RTX 4060 Ti 16 GB GPU is experiencing a price drop in Europe due to poor customer response. The GPU's lack of sales is attributed to its minor single-digit gains from its 8 GB variant, despite having double the VRAM. The card is only suitable for 1080p gaming and can perform adequately at 1440p only when using upscaling technologies like DLSS.

Portfolio Pulse from Benzinga Neuro

July 24, 2023 | 9:21 am

AZN

Amoy Diagnostics has signed a cooperation agreement with Kudos Pharmaceuticals, a unit of AstraZeneca UK, on HRD test product.

Portfolio Pulse from Charles Gross

July 24, 2023 | 9:01 am